While COVID-19, telemedicine and privacy dominated the official agenda, the issue of health policy polarization also emerged as an important topic in the presentations. As even casual observers know, American political parties and the electorate are increasingly polarized, unable to unite, and often without incentive to try to get along. As a result, Congress continues to decline legislation steadily. The polarization that has dominated the political landscape in recent years, as well as a growing gap between industry and government, are having a major impact on local healthcare. COVID-19 vaccinations, for example, are proving to be a controversial topic for healthcare workers, adding to the already difficult task hospitals and their staff face in dealing with the pandemic. Partner Joe Geraci will be on Wednesday the 9th. December 2020, at the 18th Annual Washington Health Law Summit Virtual Conference of the American Bar Association Health Law titled “Provider Challenges Around COVID-19 Relief Funding”. At the forefront of these issues is the current public health emergency. The impact of the pandemic on healthcare has been and continues to be pervasive, revolutionary and evolving.
This affected everything from A (antitrust) to Z (Z codes). Without a doubt, this year`s most powerful and discussed presentation was Taya Briley of the Washington State Hospital Association and Sheniece Smith of North Bay Healthcare discussing crisis care standards during the pandemic. Their discussion of the incredibly difficult, difficult and exhausting decisions that had to be made in the worst moments of the pandemic – which is far from over – provided further exposure to the heroic work done by so many people in healthcare and the challenges we have faced and continue to face. Another challenge for telemedicine is privacy, the third major issue addressed at the summit. Surveys discussed by René Quashie of the Consumer Technology Association showed that after cost, the biggest barrier for people trying telemedicine and other consumer health technologies was privacy concerns. Although hipAA generally works for medical privacy and providers are aware of it, some states have enacted additional laws such as the California Medical Information Privacy Act. While there is likely to be no federal legislation on the subject in the near future, the European Union`s General Data Protection Regulation could serve as a model for a broader data protection law. This organization will examine federal funding options available to public health care providers during the COVID-19 emergency. It will provide practical information, such as.B. best practices to avoid duplication of services; strategic sharing of costs incurred to meet pse, including supplies, labour and medical care; and opportunities to prepare for audits; and take into account lessons learned as the COVID-19 pandemic continues. Part of the impact of COVID-19 is a dramatic acceleration of the already rapid growth of telemedicine, which has been reflected in several presentations.
Some speakers saw telemedicine as a way to solve some of the biggest problems facing healthcare today: lack of access to care, an aging physician population, and the mental health crisis in the United States. Most speakers expressed concern that once the pandemic is under control, States will revert to higher standards for the use of telemedicine. Prior to the pandemic, payers only reimbursed a portion of telemedicine in remote areas of the country and only for certain services provided by certain types of providers. Where the public health emergency required a more flexible approach to telemedicine, many fear that the return to the old way would leave many people without the care they were finally able to get during the pandemic. While the growth of telemedicine has been dramatic, many challenges remain, including large differences between states, lack of broadband access, and privacy concerns. Nevertheless, the pandemic has shown that telemedicine can add value to patients, providers and payers. Recognizing and integrating behavioral health services into the health care system is a critical step in addressing a historical lack of resources and funding. This session explores transformative delivery models to meet behavioral health needs. clinical integration, affiliation and collaborative care through telepsychiatry and other telemedicine services; significant compliance issues; and recent regulatory changes in response to the opioid crisis and coronavirus-related public health emergencies that will impact future progress. Our panel will provide an analysis of the key players, alignment strategies and transactional trends that will shape the industry in 2021 and beyond. This polarization and litigation ultimately leads to stagnation. While we recognize that the use of the term “stagnation” may be strange given the rather turbulent and very active past 24 months, it is an accurate description of Congress` actions on health care.
This polarization leads to little or no significant congressional action on health care; and so federal agencies try to fill the void, but their actions are often challenged in court. States have also taken measures, particularly with regard to COVID-19. But their efforts are also the subject of disputes. Moreover, their actions are sometimes in direct conflict with federal measures – such as states that have ordered that there be no vaccination warrants – and with other states. This has led to a fragmented approach that discourages healthcare companies from innovating, growing and growing. For more information about this conference, visit the Washington Health Law Summit 2020 virtual conference website. The ABA Washington Health Law Summit is the leading legal conference focused on healthcare law policy, providing insight into important current and future policy issues. But as always at this conference, there are the topics chosen by the conference presidents and formally on the agenda – and then there are the topics that experienced practitioners can identify by reading between the lines. Both are discussed below. Second, some states have taken steps to restrict access to abortion during the pandemic. Specifically, the laws of the states of Texas and Mississippi, which are currently before the Supreme Court. In addition, they have passed laws that, while theoretically focused on abortion, could affect telemedicine in general.
Until the pandemic, the FDA only allowed the dispensing of mifepristone (RU 486) by a certified prescribing physician in certain healthcare facilities and prohibited prescription without an in-person medical examination. But the FDA waived those requirements during the pandemic. The results of a study on the security of remote delivery are expected to be published this month. If, as intended, it is secure, the requirements are likely to be lifted permanently. However, many states have already enacted laws or are in the process of enacting trigger laws that will prohibit it. However, if these laws are not strengthened, they could restrict telemedicine more generally. There were three other topics that were too important not to mention. First and foremost, opioid addiction and abuse continues to devastate communities and families across the country, and the pandemic has only exacerbated the problem. Given the stress of isolation, job loss, and the loss of friends and family due to COVID-19, substance abuse in all its forms has increased over the past two years. Gary Cantrell, assistant inspector general for investigations at HHS`s Office of the Inspector General, explained that HHS has worked to identify and arrest medical professionals who surprise opioids and has achieved significant success in Appalachia in recent years. Finally, although it flew well under the radar at the conference, the increase in healthcare investment in recent years has also played an important role in the growth of the healthcare industry. A significant part of this was investments by private equity firms.
To date, there have been a very small handful of cases under the False Claims Act involving a private equity firm. During a Q&A session, Lisa Re of the OIG HHS pointed out that ownership and “ownership structure” can provide incentives for corporate billing and other practices. In addition, it is possible for hhs OIG to issue guidelines regarding private equity. Jeanna Palmer Gunville, Polsinelli, PC, Chicago, IL Mr. Fischer`s practice focuses on representing individuals and businesses in civil and regulatory enforcement actions, including the False Allegations and Antitrust Matters Act.M. Fischer has represented plaintiffs and defendants in these cases, including qui-tam whistleblowers in False Claims Act cases and domestic and national internal investigations. VMG Health sponsors the 18th annual ABA Washington Health Law Summit. Be sure to attend the next session on Tuesday, December 8. Wife.
McCarty`s practice focuses on litigation and advice on government contracts, including contract termination procedures, litigation and subcontracting arbitration, as well as internal investigations. .